Gene · 84464
Papers1,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles. | Curr Oncol | 2023 | 38132377 | PubTator, text mining | PubMed |
| LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. | Genes Dev | 2023 | 38092519 | PubTator, text mining | PubMed |
| Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition? | Int J Mol Sci | 2023 | 38069345 | PubTator, text mining | PubMed |
| Cellular Responses to Widespread DNA Replication Stress. | Int J Mol Sci | 2023 | 38069223 | PubTator, text mining | PubMed |
| Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells. | Cell Chem Biol | 2023 | 38065101 | PubTator, text mining | PubMed |
| Preserving genome integrity: The vital role of SUMO-targeted ubiquitin ligases. | Cell Insight | 2023 | 38047137 | PubTator, text mining | PubMed |
| Concepts of multi-level dynamical modelling: understanding mechanisms of squamous cell carcinoma development in Fanconi anemia. | Front Genet | 2023 | 38028610 | PubTator, text mining | PubMed |
| Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques. | iScience | 2023 | 38025783 | PubTator, text mining | PubMed |
| Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients. | Open Med (Wars) | 2023 | 38025539 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. | Front Oncol | 2023 | 38023167 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors. | Nat Commun | 2023 | 37980418 | PubTator, text mining | PubMed |
| Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia. | BMC Med Genomics | 2023 | 37974167 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors. | Molecules | 2023 | 37959808 | PubTator, text mining | PubMed |
| Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review. | Onco Targets Ther | 2023 | 37933332 | PubTator, text mining | PubMed |
| Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs. | Nat Commun | 2023 | 37925537 | PubTator, text mining | PubMed |
| In Silico and In Vitro Studies of Novel Azomethines on DNA Repair Genes in Gastric Cell Lines. | Life (Basel) | 2023 | 37895364 | PubTator, text mining | PubMed |
| R-Loops in Genome Instability and Cancer. | Cancers (Basel) | 2023 | 37894353 | PubTator, text mining | PubMed |
| Insights into common fragile site instability: DNA replication challenges at DNA repeat sequences. | Emerg Top Life Sci | 2023 | 37876349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84464/papers?page=6